ArticleOpen forum infectious diseases2023

Real-World Outcomes Associated With Letermovir Use for Cytomegalovirus Primary Prophylaxis in Allogeneic Hematopoietic Cell Transplant Recipients: A Systematic Review and Meta-analysis of Observational Studies.

Ami Vyas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.